Clinical TrialMay 18, 2026, 07:06 AM
Amwell's SilverCloud Trial Shows 74.4% Engagement, Reduced Disorders
AI Summary
Amwell announced positive results from a large-scale, independently led clinical trial of its SilverCloud digital behavioral health solution, funded by the National Institute of Mental Health. The study, involving 6,205 high-risk students across 26 U.S. colleges, found that individuals offered SilverCloud were over twice as likely to engage (74.4% vs. 30.2% for traditional care). Participants also showed a 3.8% lower prevalence of mental disorders at two years, potentially avoiding up to $1.18 million in mental health-related costs within the study sample.
Key Highlights
- SilverCloud trial involved 6,205 high-risk students across 26 U.S. colleges.
- 74.4% participation with SilverCloud, compared to 30.2% with traditional solutions.
- 4.3% lower prevalence of mental disorder at six weeks with digital care.
- 4.9% lower prevalence of mental disorder at six months with digital care.
- 3.8% lower prevalence of mental disorder at two years with digital care.
- Potential economic value of up to $1.18 million in avoided mental health costs.
Price Impact
More from AMWL